Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2022 07:00 ET | Source: Synlogic, Inc.

Synlogic To Present at Upcoming Investor and Industry Conferences

CAMBRIDGE, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
January 06, 2022 07:00 ET | Source: Synlogic, Inc.

Synlogic Announces Progress Toward 2022 Clinical Milestones and Participation at Upcoming Investor Conferences

- On track to initiate Phase 3 for treatment of phenylketonuria (PKU) in H2 2022 - - Additional milestones include multiple clinical read-outs across programs including enteric hyperoxaluria and...